Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001021771-25-000050
Filing Date
2025-02-19
Accepted
2025-02-19 16:43:29
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 5796
2 INCENTIVE STOCK OPTION AWARD AGREEMENT ex99_1.htm EX-99.1 38993
  Complete submission text file 0001021771-25-000050.txt   46347
Mailing Address 40 MARCUS DRIVE MELVILLE NY 11747
Business Address 40 MARCUS DRIVE MELVILLE NY 11747 (631) 760-8100
BioRestorative Therapies, Inc. (Subject) CIK: 0001505497 (see all company filings)

EIN.: 301341024 | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-86699 | Film No.: 25641088
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 08 Industrial Applications and Services)

Mailing Address STEM CELL ASSURANCE, INC. 555 HERITAGE DRIVE JUPITER FL 33458
Business Address
Silva Francisco (Filed by) CIK: 0001527241 (see all company filings)

Type: SCHEDULE 13D/A